Dr Ellie Cannon is joined by Jane Lyons, CEO of Cancer52 and Stefano Podesta, Oncology Lead at Pfizer UK, to discuss the big challenges and opportunities in the fight against cancer within the UK. PP-UNP-GBR-7436 / November 2023

Dr Ellie Cannon is joined by Jane Lyons, CEO of Cancer52 and Stefano Podesta, Oncology Lead at Pfizer UK, to discuss the big challenges and opportunities in the fight against cancer within the UK. PP-UNP-GBR-7436 / November 2023

Dr Ellie Cannon is joined by Jane Lyons, CEO of Cancer52 and Stefano Podesta, Oncology Lead at Pfizer UK, to discuss the big challenges and opportunities in the fight against cancer within the UK.&nbsp;PP-UNP-GBR-7436 / November 2023

Innovation in cancer: Defining the future of care

Healthcare in the modern world is changing rapidly. To help make sense of today’s challenges and tomorrow’s innovations, Dr Ellie Cannon invites Pfizer UK leaders and a variety of experts from across the pharmaceutical industry, life sciences and patient community to discuss the most pressing healthcare topics. Brought to you by Pfizer Ltd. 

PP-UNP-GBR-10742 / November 2024

Science

Medicine

Health & Fitness

Life Sciences

Healthcare in the modern world is changing rapidly. To help make sense of today’s challenges and tomorrow’s innovations, Dr Ellie Cannon invites Pfizer UK leaders and a variety of experts from across the pharmaceutical industry, life sciences and patient community to discuss the most pressing healthcare topics. Brought to you by Pfizer Ltd. PP-UNP-GBR-10742 / November 2024

Share Innovation in cancer: Defining the future of care

Sign up to save your podcasts

Innovation in cancer: Defining the future of care

Innovation in cancer: Defining the future of care

More shows like Breakthroughs

The Antigen

Women's Health: menopause: unmuted

Charles² – Pharma Insights

Science Will Win

Premonición